By Chris Villani ( April 2, 2018, 2:34 PM EDT) -- A Massachusetts federal judge on Friday tossed a proposed class action against a venture capital-backed Bay State biotech company, saying its optimistic outlook about a pill-based colon infection treatment did not amount to securities fraud when an unsuccessful trial of the drug caused the company's stock to plummet....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.